ZYDUSLIFE.NS Overview

Company Profile

Related stocks

LAURUSLABS.NS • India

LAURUS LABS LIMITED

2,036.6 INR

11.37B USD 1Y +135.4%

MANKIND.NS • India

MANKIND PHARMA LIMITED

2,368.5 INR

10.11B USD 1Y -3.1%

RDY • India

Dr. Reddy's Laboratories Ltd

12.48 USD

10.4B USD 1Y -12.8%

DRREDDY.NS • India

DR. REDDY S LABORATORIES

1,197 INR

10.3B USD 1Y -3.9%

CIPLA.NS • India

CIPLA LTD

1,301 INR

10.86B USD 1Y -14%

LUPIN.NS • India

LUPIN LIMITED

1,956.5 INR

9.24B USD 1Y -0.1%

AUROPHARMA.NS • India

AUROBINDO PHARMA LTD

1,693 INR

10.07B USD 1Y +51.2%

ALKEM.NS • India

ALKEM LABORATORIES LTD.

5,279 INR

6.52B USD 1Y -4.4%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile

4 Metrics

Country

India

Region

Asia-Pacific

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High

5Y Volatility

25.1% p.a.

Max Drawdown (5Y)

-40.0%

Sharpe Ratio (5Y)

0.50

Beta Factor

0.37

Size Class

Mega Cap

Notes & Warnings

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).

Exemplary balance sheet strength: Very solid ratio of equity to debt.

Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (25.1% p.a.).

Historical Stress Test: Maximum peak-to-trough drawdown of -61.1% in the extended horizon.